The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Bryson et al., N Engl J Med 332(13):833-838 March 30, 1995.

Correspondence
PreviousPrevious
Volume 333:319-320 August 3, 1995 Number 5
NextNext

Clearance of HIV in an Infant

 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Bryson, Y. J.
-Related Article
 by Bryson, Y. J.
To the Editor: Bryson and colleagues report the spontaneous clearance of human immunodeficiency virus (HIV) infection in a baby (March 30 issue).1 Unfortunately, spontaneous clearance seems to be rare, and we have not observed it in any of 180 babies born to seropositive mothers.2 We tested for the presence of HIV in these infants two to four times during the first two months of life by means of polymerase-chain-reaction (PCR) testing of peripheral-blood mononuclear cells and HIV culture. All 33 infants with positive tests at birth or at two to four weeks of life also had positive tests on subsequent occasions and were confirmed as having HIV infection.

To demonstrate the spontaneous clearance of HIV infection, two points must be established: a confirmed diagnosis of HIV infection early in life, and the absence of infection in the child at the present time. In the case reported by Bryson et al., the latter point seems more likely, given the five years of follow-up. However, the use of PCR to test for HIV-1 RNA in plasma may help detect low-level viremia produced by cells that are inaccessible by blood sampling.

The diagnosis of infection in this infant was based on two positive HIV cultures on days 19 and 51; a third culture, on day 33, was negative. In this very unusual clinical situation, direct PCR studies of uncultured peripheral-blood mononuclear cells could have confirmed the diagnosis and allowed further sequencing and accurate nucleic-acid comparisons,3 averting possible artifacts due to culture. Since cryopreserved peripheral-blood mononuclear cells were available for extensive genetic studies on day 19, they could be used to test for HIV-1 proviral DNA by PCR. A negative result would diminish the message of hope conveyed by this unique observation.


Anne Krivine, M.D.
Pierre Lebon, M.D.
Hôpital Saint Vincent de Paul
75674 Paris, France

References

  1. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, Chen ISY. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-838. [Free Full Text]
  2. Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. Lancet 1992;339:1187-1189. [CrossRef][Medline]
  3. Wolinsky SM, Wike CM, Korber BT, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-1137. [Free Full Text]

 
To the Editor: The report by Bryson et al. is a fascinating study of the possibility that HIV was eliminated from a host. However, we believe that another explanation must be considered.

It has been well documented that maternal-to-fetal engraftment of T cells occurs regularly in infants born with severe combined immunodeficiency.1 This phenomenon may be a factor in the transmission of HIV. That T cells transferred from mother to infant are viable is shown by their ability to produce graft-versus-host disease.1 Furthermore, in babies with severe combined immunodeficiency, maternal cells have been shown to be tolerated for up to 12 months after birth.1

It is therefore possible that the HIV detected on days 19 and 51 in the infant described by Bryson et al. was that found in maternal cells. Only small numbers of maternal cells may be transferred to the fetus, resulting in the negative results of early PCR testing. Subsequently, such cells would proliferate in response to the infant's lymphocytes, resulting in increased expression of HIV. In an immunocompetent host, the maternal cells would be cleared. The result would be the apparent clearance of HIV infection in the host. The presence of HIV in maternal cells could also explain why a detectable proliferative response to HIV-1 was not found.

Genetic studies were performed to ensure that no error was made in sample labeling. Were these tests sufficiently sensitive to exclude the possibility that a low level of maternal DNA was present? Since the child was male, determination of the karyotype of the HIV-expressing cells could provide the answer.


Mark Gompels, M.B., B.S.
Gavin Spickett, D.Phil.
Newcastle General Hospital
Newcastle-upon-Tyne NE4 6BE, United Kingdom


Anne Curtis, Ph.D.
Newcastle University
Newcastle-upon-Tyne NE2 4HH, United Kingdom

References

  1. Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982;307:662-666. [Medline]

 
The authors reply:

To the Editor: We based the diagnosis of HIV-1 infection in this infant on the presence of cultured virus in samples of peripheral blood obtained from the infant on two separate occasions — an approach that is consistent with the guidelines established by the National Institutes of Health AIDS Clinical Trials Working Group and the Centers for Disease Control and Prevention.1,2,3 DNA PCR assays with peripheral-blood mononuclear cells have entailed more problems with potential laboratory contamination in other studies, although we have found the assay to be sensitive and specific.4 The infant had a positive result on DNA PCR testing, with a very low number of copies (3 per microgram of DNA), on one occasion and positive cultures on two occasions; only 1 in 1 million cells was infected. This result indicates that the infant had a very low viral load, as compared with other infected infants we and other investigators have followed sequentially during the first few months of life.4,5 We would have liked to perform all possible tests on this child, particularly on the early occasions; we were limited, however, by the small specimens available for retrospective testing and the need to gain the maximal amount of information.

We agree with Dr. Gompels and his colleagues that it is possible that infected maternal cells persisted in the infant's circulation. If the maternal cells were proliferating in the infant for several months, as the authors suggest, it would still not explain why the infant's own cells were not infected. The mother's very low viral load as evidenced by our inability to culture virus from her blood for over a year, and the presence of cell-free virus in the plasma of the infant at the time of the second positive culture (suggesting replication) make this possibility less likely.

We would also like to correct a statement in our article. Although we state that "some of the maternal HIV-1 sequences were closely related to the principal sequence from the child's samples" (page 835, righthand column, lines 35 to 37), as we state elsewhere in the article, it is not possible at this time to establish a relation between the mother's virus and that of the infant. This fact has no bearing on the central conclusion of our report; the infant was infected, as evidenced by the isolation of identical virus on two different occasions, and then became free of virus. The possibility that the virus was maternally derived has not been formally confirmed and is currently being addressed.


Yvonne J. Bryson, M.D.
Irvin S.Y. Chen, Ph.D.
UCLA School of Medicine
Los Angeles, CA 90024-1752

References

  1. Revised classification system in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43(RR-12).
  2. Virology Technical Advisory Committee. Virology manual for HIV laboratories. Bethesda, Md.: AIDS Clinical Trials Group, September 1994.
  3. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis 1994;170:996-1000. [Medline]
  4. Dickover RE, Dillon M, Gillette SG, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994;170:1279-1284. [Medline]
  5. Luzuriaga K, McQuilken P, Alimenti A, Somasundaran M, Hesselton R, Sullivan JL. Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Dis 1993;167:1008-1013. [Medline]

 


 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Bryson, Y. J.
-Related Article
 by Bryson, Y. J.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.